Spyre Therapeutics prices $350 mln follow-on share sale
Shares of Spyre Therapeutics were down 4.1% premarket after the biotech firm priced a $350 million follow-on share offering at $85 per share, an 8.3% discount to the last sale.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.